| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |